Abiopharma

🔍 Trigilio Jeffrey (Executive)

Company: XOMA Royalty Corp (XOMA)

Report Date: 2026-03-11

Detailed Transactions and Holdings:

• Acquired 90,000 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: A | equity_swap_involved: false | shares_owned_after: 90,000.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 138,462 shares of Performance Stock Units (Derivative)
  Date: 2026-03-11 | Code: A | equity_swap_involved: false | shares_owned_after: 138,462.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: Represents a grant of restricted stock units payable solely in common stock that will vest as to 25% on each of the first four anniversaries of January 12, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.
• F2: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock. The PSUs vest upon the common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date.